HilleVax, Inc. (HLVX)
NASDAQ: HLVX · Real-Time Price · USD
2.040
-0.070 (-3.32%)
At close: Aug 1, 2025, 4:00 PM
2.050
+0.010 (0.49%)
After-hours: Aug 1, 2025, 5:46 PM EDT
The Duckhorn Portfolio Market Cap
HilleVax has a market cap or net worth of $101.20 million as of August 1, 2025. Its market cap has increased by 15.22% in one year.
Market Cap
101.20M
Enterprise Value
-34.30M
1-Year Change
15.22%
Ranking
Category
Stock Price
$2.04
Market Cap Chart
Since the IPO on April 29, 2022, HilleVax's market cap has decreased from $538.26M to $101.20M, a decrease of -81.20%. That is a compound annual growth rate of -40.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 101.20M | 1.35% |
| Dec 31, 2024 | 99.85M | -86.63% |
| Dec 29, 2023 | 746.58M | 25.20% |
| Dec 30, 2022 | 596.32M | 10.79% |
| Apr 29, 2022 | 538.26M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.41B |
| Johnson & Johnson | 398.22B |
| AbbVie | 341.38B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 220.88B |
| UnitedHealth Group | 220.62B |
| Novo Nordisk | 213.92B |